Gene Query: COX6C

Dataset Description Geneva Score
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 61.75
RNA-Seq analysis of breast cancer cells after shikonin treatment 45.09
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 42.33
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 39.38
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 35.72
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 35.72
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 34.92
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 34.52
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 34.39
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 33.31
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 33.2
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 30.52
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 30.52
FBXW7 modulates stress response by post-translational modification of HSF1 28.03
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 28.03
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 26.02
Systematic discovery of endogenous human ribonucleoprotein complexes 25.57
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 25.13
Co-transcriptional loading of RNA export factors shapes the human transcriptome 24.91
RNAseq of HEK293 cells after Chtop knockdown 24.91
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 24.7
Paxillin regulates genomic networks in prostate cancer [LNCaP] 24.66
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 24.23
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 23.64
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 21.75
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 21.62
Tracking distinct RNA populations using efficient and reversible covalent chemistry 20.32
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 19.61
RNA sequencing of BT142 and TS603 cell lines 19.61
An integrative analysis of non-coding regulatory DNA variations associated with autism 19.47
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 19.1
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 19.08
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 18.74
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 18.54
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 18.4
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 18.04
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 17.68
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 17.59
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 17.59
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 17.17
Gene expression analysis of immortalized human liver progenitor-like cells in culture 16.99
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 16.36
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 16.07
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 15.83
Next generation sequencing of small RNAs isolated from exosomes in human semen 15.76
Global analysis of enhancer targets: Mosaic-seq 15.44
Mitochondrial dsRNA triggers antiviral signalling in humans 15.25
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 15.17
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 15.17
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 15.05
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 15.02
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 14.85
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 14.84
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 14.62
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 14.62
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 14.47
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 14.43
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.39
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 14.39
RNA-sequencing of healthy human skeletal myocytes 14.34
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 14.3
Single-cell analysis of human kidney organoids 14.27
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 14.23
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 14.23
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 14.2
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 14.2
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 14.06
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 14.06
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 14.04
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 14.04
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 13.89
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 13.89
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 13.63
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 13.44
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 13.41
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 13.35
Identification of transcription start sites for human A549 cell line using ReCappable-seq 13.34
RNA-Seq with and without RNase treatment in PCa cell lines 13.22
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 13.05
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 12.96
Genome wide miR-191 target profile determined by RIP and gene expression profiling 12.96
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 12.89
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 12.89
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 12.88
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 12.78
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 12.71
RNA-seq analyses of human prostate cancer cells 12.71
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 12.46
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 12.37
Genome wide expression change in LCC2 and MCF-7 cells 12.32
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 12.32
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 12.25
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 12.17
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 11.89
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 11.87
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 11.86
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 11.86
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 11.78
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 11.72
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 11.69
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 11.64
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 11.59
3’ Uridylation Expands miRNA Target Repertoire 11.58
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 11.52
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 11.52
Gene expression profiling of leukemia cells following asparagine depletion 11.46
CROP-Seq in Primary Human T Cells 11.45
Ribosomal footprinting of MDA-Parental and MDA-LM2 11.43
K562 polyA RNA-Seq 11.41
Small-molecule targeting of brachyury transcription factor addiction in chordoma 11.4
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 11.37
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 11.32
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 11.32
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 11.31
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 11.19
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 11.18
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 11.18
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 11.14
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 11.13
m6A-dependent regulation of messenger RNA stability 10.97
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 10.96
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 10.93
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 10.88
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 10.88
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 10.82
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 10.82
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 10.78
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 10.66
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 10.64
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 10.6
KLF6-dependent transcription in renal cancer cells 10.59
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 10.58
Role of microRNAs in the interaction between Salmonella and the host cell 10.46
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 10.46
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 10.41
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 10.41
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 10.41
RNA expression following TMPRSS11B overexpression or depletion 10.39
RNA-seq analysis of AML cells in response to ASLAN003 10.36
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 10.34
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 10.34
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 10.34
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 10.27
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 10.25
High-throughput sequencing of PROMPT-enriched samples. 10.12
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 10.11
Ribosomal footprinting of CN34-Parental and CN34-LM1a 10.09
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.02
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 10.01
Sensing self and nonself circular RNAs 9.98
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 9.87
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 9.87
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 9.84
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 9.84
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 9.84
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 9.81
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 9.79
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 9.78
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 9.77
Transcriptome sequencing of K-562 cells 9.75
Transcriptomic and gene ontology profiling of the human corneal cell types 9.75
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 9.72
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 9.72
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 9.71
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 9.71
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 9.71
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 9.69
mRNA expression profile of Lymphocytes 9.69
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.6
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 9.56
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 9.56
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 9.5
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 9.36
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 9.36
DART-seq: an antibody-free method for global m6A detection 9.33
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 9.28
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.21
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 9.2
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 9.18
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 9.17
Neurofibroma 9.17
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 9.17
SRSF1 role in cellular gene expression and splicing 9.13
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.13
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 9.11
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 9.11
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 9.09
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 9.07
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 9.06
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 8.99
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 8.96
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 8.95
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 8.94
Global Mapping of Human RNA-RNA Interactions 8.94
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 8.93
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 8.93
RNA editing in nascent RNA affects pre-mRNA splicing 8.9
Maturation of human iNSCs 8.87
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 8.84
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 8.83
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 8.75
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 8.7
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 8.7
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 8.68
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 8.64
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 8.62
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 8.61
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 8.61
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 8.6
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 8.58
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 8.58
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 8.53
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 8.47
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 8.42
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.34
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.34
RNA-seq analyisis of PUM2 knockout cells 8.32
Effect of BB608 on Gene Expression in HNSCC Cell Line 8.25
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 8.24
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 8.19
ARID1A and ARID1B loss in HCT116 cells 8.17
Region-specific Innate Antiviral Responses of the Human Epididymis 8.16
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 8.12
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 8.11
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 8.09
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 8.04
Transcriptomic analysis of the HOTAIR-regulated genes 8.03
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 8.0
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 7.99
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 7.95
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 7.93
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 7.93
A20 regulates canonical wnt-signaling through an interaction with RIPK4 7.9
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 7.88
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 7.88
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 7.8
Tracing Enhancer Networks using Epigenetic Traits (TENET) 7.79
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 7.78
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 7.72
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 7.61
HEK293 Heat-shock experiment 7.6
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 7.52
Identification of Atrial Fibrillation associated genes and functional non-coding variants 7.51
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 7.48
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 7.47
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 7.45
Gene expression changes caused by KRAS in MCF-10A 7.42
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 7.4
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.39
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.39
RNA-seq of RKO cells with cTAZ KO or putback 7.27
mRNA recovered upon RNF219 IP. [RNA-IP] 7.22
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 7.2
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 7.19
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 7.12
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 7.09
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.09
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 7.06
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 7.03
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 7.0
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 6.99
TOP2B disturbed the quality of human oocytes with advanced maternal age 6.94
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 6.94
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 6.94
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 6.89
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 6.88
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 6.86
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 6.81
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 6.81
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 6.8
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 6.74
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 6.64
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 6.58
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 6.58
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.56
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 6.56
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 6.53
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 6.53
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 6.44
RNA sequencing of primary human platelets and in vitro cell lines 6.43
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 6.4
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 6.4
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 6.39
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 6.39
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 6.35
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 6.28
miRNAs affected by antagomiR-17 treatment 6.24
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 6.24
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 6.19
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 6.19
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 6.09
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 6.04
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.01
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 5.96
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 5.95
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 5.93
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 5.89
Ribosome profiling upon inhibition of eIF4A 5.85
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 5.81
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 5.81
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 5.77
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.7
Trans-differentiation of human adult peripheral blood T cells into neurons 5.64
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 5.64
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 5.61
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.6
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.5
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 5.46
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 5.45
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 5.44
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.29
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.29
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.29
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 5.25
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 5.2
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 5.14
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 5.11
Patient-derived xenograft platform for metastatic melanoma 5.03
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 4.95
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.95
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 4.91
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.86
RNA-Seq of PRMT1 overexpression ECA109 cells 4.84
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.79
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 4.76
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.75
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 4.66
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 4.6
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 4.56
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.52
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 4.45
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 4.4
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.3
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.29
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.29
Role of cervicovaginal microbiota in genital inflammation 4.29
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 4.28
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 4.25
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 4.18
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 4.17
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 4.17
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 4.13
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 4.12
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 4.12
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 4.11
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 4.03
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 4.02
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 4.02
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.01
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 4.01
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 3.97
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 3.91
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 3.91
Measure transcript integrity using RNA-seq data 3.9
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 3.85
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.79
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 3.74
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 3.72
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 3.71
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.7
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.7
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 3.68
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 3.67
RNAseq in Alzheimer's Disease patients 3.57
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.56
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.56
Effect of PRDM11 depletion in U2932 cells 3.48
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.42
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 3.4
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.39
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 3.39
Regulation of hypoxia-inducible factor activity by ZMYND8 3.37
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 3.27
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 3.24
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 3.24
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 3.24
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 3.2
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.1
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.1
Differential Protein Occupancy Profiling of the mRNA Transcriptome 3.09
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 3.09
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.95
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.95
p63 controls the enhancer landscape during keratinocyte differentiation 2.91
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 2.86
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 2.85
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.8
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.8
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.71
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 2.67
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.63
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 2.62
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 2.61
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.57
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.57
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.56
RNA Sequencing of Human iPS derived Cardiomyocytes 2.55
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.44
Iron response of HepG2 cells 2.43
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.43
Solid phase chemistry to covalently and reversibly capture thiolated RNA 2.42
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.41
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.4
MARCKS and lnc-MARCKS act as inflammation regulators 2.38
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 2.35
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.31
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.31
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 2.29
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.29
A single-cell transcriptome atlas of the human pancreas 2.23
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.15
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.13
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.1
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.09
Dilated cardiomyopathy vs Myocarditis 1.98
Transcriptional landscape changes during human embryonic stem cell derivation 1.97
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.92
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.91
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 1.91
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 1.91
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.89
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 1.83
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.82
miR-93 Targets in Human Endothelial Cells 1.77
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.71
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 1.69
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.64
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.57
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.56
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.52
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.52
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.51
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.5
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.5
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.49
Metastasis in triple-negative breast cancer 1.49
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.47
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.44
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.44
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.44
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.42
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.4
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.35
Copper Regulation of HIF-1 Transcription Activity 1.35
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.26
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.26
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.26
Expression analysis of the TAF1 syndrome 1.25
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.25
Exogenous rescue of KLHL9 in SF210 cell line 1.19
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.17
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.15
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.06
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.05
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.05
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.04
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.03
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.03
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.93
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.92
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.85
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 0.85
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.77
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.77
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.69
Modeling Human Cancer-induced Cachexia (Human) 0.67
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.64
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.64
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 0.63
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.63
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.62
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.61
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.55
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.55
SOX11 knockdown in B-ALL cell lines 0.53
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 0.51
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.51
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.46
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.45
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.44
mRNA-sequencing of breast cancer subtypes and normal tissue 0.43
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.43
Aging-associated patterns in the expression of human endogenous retroviruses 0.4
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 0.39
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.39
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.36
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.29
siRNA-mediated knockdown 0.25
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.24
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.23
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.21
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.21
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.2
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.12
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.11
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.09
RNA-Seq and expression data from human adipose tissue 0.09
HEK293 TFAM Knockout Expression Study 0.08
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.04
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation